Avance Incontinence Care Solution
NDC Package 70936-112-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Avance Incontinence Care (benzethonium chloride) solution is apply to affected areaSpray on a clean cloth and remove urine, feces and vomit.Cleanse skin of all residue and wipe with clean cloth to dry. This formulation utilizes a solution delivery system. Marketed by Smart Choice Medical Inc., this product is identified by NDC 70936-112 and is authorized under FDA application M003.

Identification & Billing

NDC Package Code
70936-112-08
Package Description
237 g in 1 BOTTLE
Product Code
70936-112
11-Digit Billing Format
70936011208
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Avance Incontinence Care
Non-Proprietary Name
Benzethonium Chloride
Substance Name
Benzethonium Chloride
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
BENZETHONIUM CHLORIDE .12 g/100g
Usage Information
Apply to affected areaSpray on a clean cloth and remove urine, feces and vomit.Cleanse skin of all residue and wipe with clean cloth to dry. If the surface area is massive, rinse affected area with warm water before using.

Regulatory & Marketing

Labeler Name
Smart Choice Medical Inc.
Product Type
Human Otc Drug
FDA Application #
M003
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-29-2022
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70936-112-08 identifies a specific commercial package of 237 g in 1 bottle of Avance Incontinence Care, a human over the counter drug labeled by Smart Choice Medical Inc.. This solution is formulated for topical use and contains benzethonium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Smart Choice Medical Inc. on June 29, 2022. The current certification is valid through December 31, 2027.

How is this Smart Choice Medical Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70936011208. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70936-112-08
11-Digit CMS (5-4-2)
70936-0112-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.